The Vanguard Study: Testing a New Way to Screen for Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
UMC Utrecht
BeOne Medicines
Bayer
ViroMissile, Inc.
Arcus Biosciences, Inc.
AstraZeneca
Tizona Therapeutics, Inc
Essen Biotech
Clasp Therapeutics, Inc.
Eli Lilly and Company
Brigham and Women's Hospital
Baylor College of Medicine
University of Colorado, Denver
MacroGenics
Alliance for Clinical Trials in Oncology
City of Hope Medical Center
Daiichi Sankyo
University of Nebraska
Eli Lilly and Company
Adela, Inc
Second Life Therapeutics
Ocellaris Pharma, Inc.
Medical College of Wisconsin
Elephas
Var2 Pharmaceuticals
OncoNano Medicine, Inc.
Mayo Clinic
Memorial Sloan Kettering Cancer Center
NeoTX Therapeutics Ltd.
BicycleTx Limited
BicycleTx Limited
UNC Lineberger Comprehensive Cancer Center
Rondo Therapeutics
Actym Therapeutics, Inc.
Institut Bergonié
Washington University School of Medicine
Travera Inc
University of Colorado, Denver
Shanghai Escugen Biotechnology Co., Ltd
Washington University School of Medicine
Västernorrland County Council, Sweden
Palleon Pharmaceuticals, Inc.
Merck Sharp & Dohme LLC
Jonsson Comprehensive Cancer Center
Cancer Research UK
Incyte Corporation
UNC Lineberger Comprehensive Cancer Center
Genentech, Inc.
TransThera Sciences (Nanjing), Inc.